Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-01-24 00:00:00 ET · period of report 2024-01-20 · accession 0001439222-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-24 | 2024-01-20 | AGIO | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | +5,448 | 14.9K | +58% | $0 |
| D | 2024-01-24 | 2024-01-24 | AGIO | Milanova Tsveta | Chief Commercial Off | S - Sale+OE | $21.64 | -1,618 | 13.2K | -11% | -$35.0K |
| D | 2024-01-24 | 2024-01-20 | AGIO | Milanova Tsveta | Chief Commercial Off | M - OptEx | $0.00 | -5,448 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-01-20 | M | A | 5,448 | $0.00 | 14,852 | D | — | — | |
| 2 | Common | Common stock | 2024-01-24 | S | D | 1,618 | $21.64 | 13,234 | D | — | — | |
| 3 | Derivative | Performance share units | 2024-01-20 | M | D | 5,448 | $0.00 | 0 | D | — · — to — | 5,448 Common stock | (F2) Each performance share unit represents a contingent right to receive one share of the issuer's common stock. (F3) The PSUs were granted on January 3, 2023. The PSUs vest upon the achievement of a specified research milestone. The performance criteria for the specified research milestone was determined to have been met on January 20, 2024, resulting in the vesting of the PSUs. Vested shares will be delivered to the reporting person within three business days after such shares become vested. |